Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2018 August;153(4) > Giornale Italiano di Dermatologia e Venereologia 2018 August;153(4):549-56

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW  PSYCHOCUTANEOUS DISEASES 

Giornale Italiano di Dermatologia e Venereologia 2018 August;153(4):549-56

DOI: 10.23736/S0392-0488.18.05978-3

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

Psychopharmacology

Sahil SEKHON 1, George KROUMPOUZOS 2, 3, John KOO 1

1 Department of Dermatology, University of California, San Francisco, CA, USA; 2 Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, RI, USA; 3 Department of Dermatology, Medical School of Jundiaí, São Paulo, Brazil


PDF


Most dermatologists evaluate and treat patients with psychological or psychiatric issues related to their skin disease. These patients often require psychopharmacologic therapies. Therefore, it is important for dermatologists to be familiar with psychopharmacologic treatments for diseases that fit into the overlap between psychiatry and dermatology. This review aims to provide a concise overview of psychopharmacology as it applies to dermatology. Psychotropic medications commonly used in psychodermatology, including antidepressants, antipsychotics, and anxiolytics, are reviewed; safety profile and dosing recommendations are discussed.


KEY WORDS: Pharmaceutical preparations - Disease management - Antidepressive agents - Antipsychotic agents - Anti-anxiety agents

top of page